Decreased expression of the metastasis suppressor gene KAI1 in gastric cancer

Cancer Letters

Volumn 129, Issue 2, 1998, Pages 229-234

  Hinoda, Yuji ^a   Adachi, Yasushi ^a   Takaoka, Akinori ^a   Mitsuuchi, Hideki ^a   Satoh, Yukihiko ^a   Itoh, Fumio ^a   Kondoh, Yoshihiro ^a   Imai, Kohzoh ^a  

^a SAPPORO MEDICAL UNIVERSITY   (Japan)

Author keywords

Gastric cancer; Intestinal metaplasia; KAI1; Metastasis suppressor gene

Indexed keywords

ANIMAL CELL; ARTICLE; CANCER STAGING; CONTROLLED STUDY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INTESTINE METAPLASIA; LIVER METASTASIS; MAJOR CLINICAL STUDY; NONHUMAN; PERITONEUM METASTASIS; PRIORITY JOURNAL; STOMACH CANCER; STOMACH FUNDUS; TUMOR SUPPRESSOR GENE;

ADENOCARCINOMA; ANTICARCINOGENIC AGENTS; ANTIGENS, CD; COLONIC NEOPLASMS; FLOW CYTOMETRY; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMUNOENZYME TECHNIQUES; KANGAI-1 PROTEIN; MEMBRANE GLYCOPROTEINS; PROTO-ONCOGENE PROTEINS; RNA, MESSENGER; STOMACH NEOPLASMS; TUMOR CELLS, CULTURED;

EID: 0032546877     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3835(98)00112-8     Document Type: Article

References (21)

1. Tahara E. Genetic alterations in human gastrointestinal cancers - The application to molecular diagnosis. Cancer. 75(Suppl.):1995;1410-1417.
2. Hong R.L., Lee W.J., Shun C.T., Chu J.S., Chen Y.C. Expression of CD44 and its clinical implication in diffuse-type and intestinal-type gastric adenocarcinomas. Oncology. 52:1995;334-339.
3. Yamaguchi A., Saito M., Giolida A., Takeuchi K., Hirose K., Nakagawara G., Urano T., Furukawa K., Shiku H. Expression of CD44 variant exons 8-10 in gastric cancer. Jpn. J. Cancer Res. 86:1995;1166-1171.
4. Dong J.T., Lamb P.W., Rinker-Schaeffer C.W., Vukanovic J., Ichikawa T., Isaacs J.T., Barrett J.C. KAI1, a metastasis suppressor gene for prostate cancer on human chromosome 11p11.2. Science. 268:1995;884-886.
5. Wright M.D., Tomlinson M.G. The ins and outs of the transmembrane 4 superfamily. Immunol. Today. 15:1994;588-594.
6. Gaugitsch H.W., Hofer E., Huber N.E., Schnabl E., Baumruker T. A new superfamily of lymphoid and melanoma cell proteins with extensive homology to Schistosoma mansoni antigen Sm23. Eur. J. Immunol. 21:1991;377-383.
7. Fukudome K., Furuse M., Imai T., Nishimura M., Takagi S., Hinuma Y., Yoshie O. Identification of membrane antigen C33 recognized by monoclonal antibodies inhibitory to human T-cell leukemia virus type 1 of C33 antigen in HTLV-1-positive T cells. J. Virol. 66:1992;1394-1401.
8. Nojima Y., Hirose T., Tachibana K., Tanaka T., Shi L., Doshen J., Freeman G.J., Schlossman S.F., Morimoto C. The 4F9 antigen is a member of the tetra spans transmembrane protein family and functions as an accessory molecule in T cell activation and adhesion. Cell. Immunol. 152:1993;249-260.
9. Ueda T., Ichikawa T., Tamura J., Mikata A., Akakura K., Akimoto S., Imai T., Yoshie O., Shiraishi T., Yatani R., Ito H., Shimazaki J. Expression of the KAI1 protein in benign prostatic hyperplasia and prostate cancer. Am. J. Pathol. 149:1996;1435-1440.
10. Saiki R.K., Scharf S., Faloona F., Mullis K.B., Horn G.T., Erlich H., Arnheim N. Enzymatic amplification of β-globin genomic sequences and restriction site analysis for diagnosis of sickle cell anemia. Science. 230:1985;1350-1354.
11. Sato Y., Mukai K., Watanabe S., Goto M., Shimosato Y. The AMeX method. A simplified technique of tissue processing and paraffin embedding with improved preservation of antigens for immunostaining. Am. J. Pathol. 125:1986;431-435.
12. Akashi H., Hinoda Y., Itoh F., Adachi M., Endo T., Imai K. A novel gastric-cancer-associated mucin antigen defined by a monoclonal antibody A3D4. Int. J. Cancer. 73:1997;795-801.
13. Japanese Classification of Gastric Carcinoma, Japanese Research Society for Gastric Cancer, Kanehara, Tokyo, 1995.
14. Chong J.-M., Fukayama M., Hayashi Y., Takizawa T., Koike M., Konishi M., Kikuchi-Yanoshita R., Miyaki M. Microsatellite instability in the progression of gastric carcinoma. Cancer Res. 54:1994;4595-4597.
15. Correa P., Sasano N., Stemmerman G.N., Haenszel W. Pathology of gastric carcinoma in Japanese populations: comparisons between Miyagi prefecture and Hawaii. J. Natl. Cancer Inst. 51:1973;1449-1559.
16. Imai T., Murayama H. Time trend in the prevalence of intestinal metaplasia in Japan. Cancer. 52:1983;353-361.
17. Hertzog P.J., Robinson H.C., Ma J., Mackay I.R., Linnane A.W. Oncofetal expression of the human intestinal mucin glycoprotein antigens in gastrointestinal epithelium defined by monoclonal antibodies. Int. J. Cancer. 48:1991;355-363.
18. Watanabe R., Johzaki H., Iwasaki H., Kikuchi M., Ikeda S. A new tumor-associated antigen defined by a monoclonal antibody directed to gastric adenocarcinoma. Cancer. 71:1993;2139-2147.
19. Ohe Y., Hinoda Y., Irimura T., Imai K., Yachi A. Expression of sulfated carbohydrate chains detected by monoclonal antibody 91.9H in human gastric cancer tissues. Jpn. J. Cancer Res. 85:1994;400-408.
20. Guo X., Friess H., Graber H.U., Kashiwagi M., Zimmermann A., Korc M., Buhler M.W. KAI1 expression is up-regulated in early pancreatic cancer and decreased in the presence of metastases. Cancer Res. 56:1996;4876-4880.
21. Adachi M., Taki T., Ieki Y., Huang C.L., Higashiyama M., Miyake M. Correlation of KAI1/CD82 gene expression with good prognosis in patients with non-small cell lung cancer. Cancer Res. 56:1996;1751-1755.